secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2026-09-14T12:00:11+00:00
Accession:  0001437749-26-030228
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals furnishes investor presentation with no material new details
--------------------------------------------------------------------------------

- Furnished updated investor presentation for meetings starting Sept 8, 2026.
- Presentation may be used in future investor and analyst meetings with modifications.
- No financial or operational specifics disclosed in the 8-K body.
- Exhibit content not available; no material changes to operations reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926030228/0001437749-26-030228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926030228/nrxp20260911_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer